MGD006 is a bispecific CD3 × CD123 dual-affinity re-targeting (DART) molecule that binds T lymphocytes and cells expressing CD123, an antigen up-regulated in several hematological malignancies including AML. The gene discussed is IL3RA; the disease is acute myeloid leukemia.